CRISPR is a gene-editing system found in bacteria that guides precise DNA changes, powering biotech breakthroughs and ethical debates.
Anthropic is launching an internal drug-discovery program to develop AI tools for life sciences, focusing on neglected diseases. The effort aims to create drug-discovery capabilities in-house and partner with industry, while navigating the costly regulatory path and uncertain clinical development timelines.
Researchers have used CRISPR to deactivate an allergy-causing gene in dogs, creating two beagle puppies with saliva and fur that no longer trigger common dog allergies. The work, published in the CRISPR Journal, shows a potential path for allergy-free pets, though wide adoption will take years and raises ethical questions.